top of page

Swissmedic: eCTD v4.0 Implementation Guide published

Earlier today (17 March 2023) Switzerland's SwissMedic released published the "Implementation Guide for eCTD v4.0" and the implementation package contains a spreadsheet of context, and submission unit types, Swiss eCTD v4.0 Implementation Guide Version 1.0 are now available for download.

The eCTD 4.0 is an upgrade to the previous eCTD 3.2.2 format and includes several new features, including enhanced user guidance and additional regional information, ensuring quality, consistency, and efficiency of regulatory submissions and reviews for human drugs and biologics.


eCTD 4.0 is designed to streamline the process of submitting and reviewing regulatory information by standardizing the format of submissions and facilitating information exchange between regulatory authorities and sponsors.


This technical document describes how the eCTD v4.0 specification can be implemented for Swiss purposes closely following the EU implementation guide. The next step is preparing Swissmedic's technical infrastructure for receiving and reviewing eCTD v4.0 applications.


The technical specifications and implementation guide for the Swiss Module 1 of the Electronic Common Technical Document (eCTD) version 4.0 are outlined in this document, which utilizes the HL7 Version 3 Regulated Product Submission (RPS) Release 2 Normative for human medicinal products.


This document only comprises the Swiss Module 1 part of the eCTD XML message including the Regional Administrative and CH-specific Product Information.


Click this LINK to download the swiss medic's eCTD4.0 Implementation package.

I Sometimes Send Newsletters

Thanks for submitting!

  • LinkedIn
  • Facebook
  • Twitter
  • Instagram

DISCLAIMER

The views expressed in this publication do not necessarily reflect the views of any guidance of government, health authority, it's purely my understanding. This Blog/Web Site is made available by a regulatory professional, is for educational purposes only as well as to give you general information and a general understanding of the pharmaceutical regulations, and not to provide specific regulatory advice. By using this blog site you understand that there is no client relationship between you and the Blog/Web Site publisher. The Blog/Web Site should not be used as a substitute for competent pharma regulatory advice and you should discuss from an authenticated regulatory professional in your state.  We have made every reasonable effort to present accurate information on our website; however, we are not responsible for any of the results you experience while visiting our website and request to use official websites.

bottom of page